GLAUKOS Corp Revenue
GLAUKOS Corp (GKOS) reported Revenue of $185.61 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Income Statement
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-07-29
- GLAUKOS Corp revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $185.61M, a 49.54% increase year-over-year.
- GLAUKOS Corp revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $150.57M, a 41.16% increase year-over-year.
- GLAUKOS Corp revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was $143.12M, a 35.66% increase year-over-year.
- GLAUKOS Corp revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $133.54M, a 38.14% increase year-over-year.
- GLAUKOS Corp revenue from contract with customer, excluding assessed tax for fiscal 2025 was $507.44M, a 32.33% increase from fiscal 2024.
- GLAUKOS Corp revenue from contract with customer, excluding assessed tax for fiscal 2024 was $383.48M, a 21.85% increase from fiscal 2023.
- GLAUKOS Corp revenue from contract with customer, excluding assessed tax for fiscal 2023 was $314.71M, a 11.26% increase from fiscal 2022.
- GLAUKOS Corp revenue from contract with customer, excluding assessed tax for fiscal 2022 was $282.86M, a 3.79% decline from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $185.61M 10-Q · filed 2026-07-29 | $336.18M 10-Q · filed 2026-07-29 | $479.30M derived: sum of 3 quarters · filed 2026-07-29 | $612.84M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $150.57M 10-Q · filed 2026-04-30 | $293.69M derived: sum of 2 quarters · filed 2026-04-30 | $427.23M derived: sum of 3 quarters · filed 2026-04-30 | $551.35M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $143.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $276.66M derived: sum of 2 quarters · filed 2026-02-23 | $400.78M derived: sum of 3 quarters · filed 2026-07-29 | $507.44M 10-K · filed 2026-02-23 |
| 2025-09-30 | $133.54M 10-Q · filed 2025-10-31 | $257.66M derived: sum of 2 quarters · filed 2026-07-29 | $364.32M 10-Q · filed 2025-10-31 | $469.82M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $124.12M 10-Q · filed 2026-07-29 | $230.78M 10-Q · filed 2026-07-29 | $336.28M derived: sum of 3 quarters · filed 2026-07-29 | $432.95M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $106.66M 10-Q · filed 2026-04-30 | $212.16M derived: sum of 2 quarters · filed 2026-04-30 | $308.83M derived: sum of 3 quarters · filed 2026-04-30 | $404.52M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $105.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $202.17M derived: sum of 2 quarters · filed 2026-02-23 | $297.86M derived: sum of 3 quarters · filed 2026-02-23 | $383.48M 10-K · filed 2026-02-23 |
| 2024-09-30 | $96.67M 10-Q · filed 2025-10-31 | $192.36M derived: sum of 2 quarters · filed 2025-10-31 | $277.98M 10-Q · filed 2025-10-31 | $360.35M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-30 | $95.69M 10-Q · filed 2025-08-04 | $181.31M 10-Q · filed 2025-08-04 | $263.68M derived: sum of 3 quarters · filed 2026-02-23 | $341.73M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-31 | $85.62M 10-Q · filed 2025-05-01 | $167.99M derived: sum of 2 quarters · filed 2026-02-23 | $246.03M derived: sum of 3 quarters · filed 2026-02-23 | $326.43M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $82.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $160.41M derived: sum of 2 quarters · filed 2026-02-23 | $240.81M derived: sum of 3 quarters · filed 2026-02-23 | $314.71M 10-K · filed 2026-02-23 |
| 2023-09-30 | $78.05M 10-Q · filed 2024-11-05 | $158.45M derived: sum of 2 quarters · filed 2024-11-05 | $232.35M 10-Q · filed 2024-11-05 | $303.57M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $80.40M 10-Q · filed 2024-08-02 | $154.30M 10-Q · filed 2024-08-02 | $225.53M derived: sum of 3 quarters · filed 2024-08-02 | $296.79M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $73.90M 10-Q · filed 2024-05-03 | $145.13M derived: sum of 2 quarters · filed 2024-05-03 | $216.40M derived: sum of 3 quarters · filed 2024-05-03 | $289.08M derived: sum of 4 quarters · filed 2024-05-03 |
| 2022-12-31 | $71.23M 10-K · filed 2023-02-24 | $142.50M derived: sum of 2 quarters · filed 2023-11-01 | $215.18M derived: sum of 3 quarters · filed 2023-11-01 | $282.86M 10-K · filed 2025-02-25 |
| 2022-09-30 | $71.27M 10-Q · filed 2023-11-01 | $143.95M derived: sum of 2 quarters · filed 2023-11-01 | $211.63M 10-Q · filed 2023-11-01 | $284.88M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | $72.69M 10-Q · filed 2023-08-02 | $140.37M 10-Q · filed 2023-08-02 | $213.61M derived: sum of 3 quarters · filed 2023-08-02 | $288.32M derived: sum of 4 quarters · filed 2023-08-02 |
| 2022-03-31 | $67.68M 10-Q · filed 2023-05-04 | $140.92M derived: sum of 2 quarters · filed 2023-05-04 | $215.63M derived: sum of 3 quarters · filed 2023-05-04 | $293.72M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $73.24M 10-K · filed 2023-02-24 | $147.95M derived: sum of 2 quarters · filed 2023-02-24 | $226.04M derived: sum of 3 quarters · filed 2023-02-24 | $294.01M 10-K · filed 2024-02-23 |
| 2021-09-30 | $74.71M 10-K · filed 2023-02-24 | $152.80M derived: sum of 2 quarters · filed 2023-02-24 | $220.77M 10-Q · filed 2022-11-04 | $294.00M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-06-30 | $78.09M 10-K · filed 2023-02-24 | $146.06M 10-Q · filed 2022-08-05 | $219.29M derived: sum of 3 quarters · filed 2023-02-24 | $284.13M derived: sum of 4 quarters · filed 2023-02-24 |
| 2021-03-31 | $67.97M 10-K · filed 2023-02-24 | $141.20M derived: sum of 2 quarters · filed 2023-02-24 | $206.03M derived: sum of 3 quarters · filed 2023-02-24 | $237.59M derived: sum of 4 quarters · filed 2023-02-24 |
| 2020-12-31 | $73.23M 10-K · filed 2022-02-28 | $138.06M derived: sum of 2 quarters · filed 2022-02-28 | $169.62M derived: sum of 3 quarters · filed 2022-02-28 | $224.96M 10-K · filed 2023-02-24 |
| 2020-09-30 | $64.83M 10-K · filed 2022-02-28 | $96.39M derived: sum of 2 quarters · filed 2022-02-28 | $151.72M 10-Q · filed 2021-11-08 | $217.57M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $31.56M 10-K · filed 2022-02-28 | $86.89M 10-Q · filed 2021-08-05 | $152.74M derived: sum of 3 quarters · filed 2022-02-28 | $211.25M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $55.34M 10-K · filed 2022-02-28 | $121.19M derived: sum of 2 quarters · filed 2022-02-28 | $179.69M derived: sum of 3 quarters · filed 2022-02-28 | $238.29M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $65.85M 10-K · filed 2021-03-01 | $124.36M derived: sum of 2 quarters · filed 2021-03-01 | $182.96M derived: sum of 3 quarters · filed 2021-03-01 | $236.98M 10-K · filed 2022-02-28 |
| 2019-09-30 | $58.51M 10-K · filed 2021-03-01 | $117.11M derived: sum of 2 quarters · filed 2021-03-01 | $171.13M 10-Q · filed 2020-11-05 | $225.21M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $58.60M 10-K · filed 2021-03-01 | $112.63M 10-Q · filed 2020-08-07 | $166.70M derived: sum of 3 quarters · filed 2021-03-01 | $210.61M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $54.03M 10-K · filed 2021-03-01 | $108.10M derived: sum of 2 quarters · filed 2021-03-01 | $152.01M derived: sum of 3 quarters · filed 2021-03-01 | $195.17M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $54.08M 10-K · filed 2020-03-02 | $97.98M derived: sum of 2 quarters · filed 2020-03-02 | $141.15M derived: sum of 3 quarters · filed 2020-03-02 | $181.28M 10-K · filed 2021-03-01 |
| 2018-09-30 | $43.91M 10-K · filed 2020-03-02 | $87.07M derived: sum of 2 quarters · filed 2020-03-02 | $127.20M 10-Q · filed 2019-11-06 | $168.85M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $43.16M 10-K · filed 2020-03-02 | $83.29M 10-Q · filed 2019-08-08 | $124.94M derived: sum of 3 quarters · filed 2020-03-02 | $165.36M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $40.13M 10-K · filed 2020-03-02 | $81.78M derived: sum of 2 quarters · filed 2020-03-02 | $122.19M derived: sum of 3 quarters · filed 2020-03-02 | $163.48M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $41.65M 10-K · filed 2019-02-28 | $82.06M derived: sum of 2 quarters · filed 2019-02-28 | $123.35M derived: sum of 3 quarters · filed 2019-02-28 | $159.25M 10-K · filed 2020-03-02 |
| 2017-09-30 | $40.41M 10-K · filed 2019-02-28 | $81.70M derived: sum of 2 quarters · filed 2019-02-28 | $117.60M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $41.28M 10-K · filed 2019-02-28 | $77.19M 10-Q · filed 2018-08-06 | ||
| 2017-03-31 | $35.91M 10-K · filed 2019-02-28 | |||
| 2016-12-31 | $114.40M 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |